There were rumors of an incredible 7,599,700 share trade in Hemispherx stock. A detailed review of the After Hours trading log at Nasdaq did not confirm those reports but did reveal unusually large bock trades nonetheless. This follows a day of renewed activity on the stock as investors began to feel more confident that the company would receive final word from the FDA on their application for Ampligen as a treatment for Chronic Fatigue Syndrome. That decision is now 18 days late. (Biomedreports)
The Market Guardian has also heard some rumors floating around that there are BIG buyers scooping up shares from overseas. The trading activity is very positive for HEB investors. Now that they are included in the Russell the big funds will be reallocating their capital towards HEB. Obviously the approval of Ampligen for CFS is still of primary importance to a major move upward in the stock and we think that is VERY close.
FREE HEB Company Analysis Here
Because Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for both passive and active investment strategies, many investors rush in to take shares of the newly listed companies. Interestingly, final membership lists posted for the Russell Global, Russell 3000, Russell 1000®, Russell 2000®, Russell Midcap® and Russell Microcap indexes won’t become official until June 29, but that didn’t keep the excitement from continuing after hours for some investors with big block buys and volume on Hemispherx BioPharma, Inc. (AMEX:HEB) 2.85 +0.45 (18.75%) Courtesy of Biomedreports. Another article that shows HEB is for real Stockmarketnewz
HEB Analysis Below
7 Comments
Nice article…..If FDA approved It will be just like DNDN.
I wonder who the overseas buyer was? It was a huge buy.
Here’s a link to the 7.5 million share trade at 4:02. It obviously was a Market buy at Close order.
http://quotes.freerealtime.com/dl/frt/M?&symbol=HEB&type=Time%26Sales&filter=0&IM=quotes&SA=quotes|Time%26Sales&lastTime=26-Jun-2009%2016:05:57&extra=2
We all knew the day would come sooner or later but it seems the caves of the irresponsible “journalists” are finally imploding. It may be just the tip of the berg as defined in this link http://satwaves.com/blog/2009/06/26/sec-investigating-illegal-naked-short-selling/ but its just a matter of time that the guilty who overlooked some details along the way will soon be their demise. Case in point, Adam’s Ocukus article of 6/22 reads, “according to a source familiar with the plans”. Could this be a source among many who assist in illegal activity?..Possibly, but it’s a starting point that may justify beginning a thorough investigation. Intentional and continuous “bashing” of specific stocks such as HEB leaves many to believe that there are ulterior motives of profiteering by indirect means either through close family or associates. As the SEC article points out..It’s going to only take one to bring down the house of cards. The SEC’s charter should be to expose and prosecute these so called corrupt “journalists”, funds, manipulators and even button pushing celebrities who attempt to cover up their own activity with petitions, articles and offerings of TRUST. I invite anyone who concurs with my post to cut and paste it to as many message and comment boards as possible as I know The Street will instruct Yahoo to ban my posts on this topic. Thank you for your time I wish all honest investor well. (vincethetoolman@yahoo.com)
Below is an updated technical analysis on HEB for all those interested!
http://billiondollarmission.blogspot.com/2009/06/heb-poised-to-be-next-dndn.html
Thanks BDM for sharing. This stock sure looks like it has some surprises coming!
How in the world can a CFS drug be compared to a drug that might replace chemo as we know it??????… I swear the stupid things people say..
The fact is most people with CFS – a million in US alone – will have access to a medically legitimate course of treatment. This will be quite enough to drive stock up on news of a CRL from FDA. Debilitating effects of CFS and social costs are explored along with very much information on the disease can all be found on CDC.gov website. It is a very costly disease on societal scale. Not as great as heart disease, diabetes or cancer but cery costly effect.
.
One Trackback
[...] Could HEB be the next DNDN? HEB Could Be The Next DNDN! [...]